ERBB2 and invasive carcinoma: A similar finding was reported by Zhao and colleagues and they considered that there is a small undetermined percentage of amplified HER2 without protein over-expression.40 The same study and other FISH studies on invasive carcinoma also reported rare 3+ IHC tumours that were non-amplified,40–43 however, we did not detect any such cases.